Matthew Ippolito, M.D., Ph.D. is an Assistant Professor of Medicine and the Director of Clinical Epidemiology for the Southern and Central Africa International Centers of Excellence for Malaria Research (ICEMR). He received his A.B. from Dartmouth College and his M.D. from the Geisel School of Medicine at Dartmouth. He completed his Internal Medicine Internship and Residency at the University of California, San Francisco, and fellowships in Infectious Diseases and Clinical Pharmacology at the Johns Hopkins University School of Medicine where he received his Ph.D. in Clinical Investigation from the Johns Hopkins Bloomberg School of Public Health. He also served in the Peace Corps in Ghana, West Africa.
Dr. Ippolito specializes in global health and tropical infectious diseases with a research focus on malaria in sub-Saharan Africa. His NIH-supported research program explores the clinical pharmacology of antimalarial drugs and the genetic epidemiology of drug resistance. In his role as Director of Clinical Epidemiology for the Southern and Central Africa ICEMR, Dr. Ippolito designs and oversees clinical, translational, and epidemiological studies of malaria. Dr. Ippolito also serves as a Phase I and II clinical trialist for the LONGEVITY consortium, established to develop and deploy long-acting nanoformulations of essential anti-infective drugs. He is also a co-developer of a computer vision-based machine learning platform for malaria diagnostic and research applications, and serves on the editorial board of Frontiers in Malaria.